Hyloris Pharmaceuticals SA

About Hyloris Pharmaceuticals SA

Hyloris is a specialty biopharma company dedicated to addressing unmet medical needs by innovating, reinventing, and optimizing existing medications. Their mission is to deliver significant improvements for patients, healthcare professionals, and payors through reformulation and repurposing, leveraging established regulatory pathways like the FDA's 505(b)(2) to reduce development timelines, costs, and risks.

Products & Services

Sotalol IV:A treatment for atrial fibrillation, currently in early phases of commercialization with partners.

Maxigesic(r) IV:A non-opioid post-operative pain treatment, also in early commercialization stages with partners.

High Barrier Generic Product:One approved high barrier generic product launched in the U.S., with two more in development.

Portfolio of Value-Added Medicines:A broad patented portfolio of 19 reformulated and repurposed medicines aimed at offering significant advantages over existing alternatives (as of 25 September 2024).

Specialties

Reformulation and repurposing of existing medications Value-added medicines under 505(b)(2) regulatory pathways Innovative drug development for unmet medical needs

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Non-dilutive funding (Grant and Recoverable Advance) T: - FT: Non-dilutive funding (Grant and Recoverable Advance)	A: 1080000 MR: - FA: EUR 1 million FAN: 1080000	D: 2023-06-08 FD: 2023-06-08	1 investors

Non-dilutive funding (Grant and Recoverable Advance) Latest

2023-06-08

$1.1M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Stefan Yee

Chairman and Non-Executive Director

L

Leon Van Rompay

Non-Executive Director

M

Mélanie Mestdagt

independent director

V

Vincent Van Dessel

independent director

R

Revital Rattenbach

independent director

S

Stijn Van Rompay

co-chief executive officer & co-founder

View 7 more team members with Pro

Unlock Full Team Directory

Recent News